[/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
During a hearing before the House Energy Committee examining the drug supply chain, Association for Accessible Medicines (AAM) President/CEO Chester Davis argued that generic drug markets are fundamentally different than those for innovators and have increased supply chain pressures, “For every $100 spent on dispensing generic medicines in this country, approximately $65 goes to the distribution and reimbursement of those products by the members of the supply chain.” Opening statements from other industry stakeholders are available online.
[/membership]